Creating Biomedical Technologies to Improve Health

Search form



NIBIB in the News • October 22, 2014

NIBIB's Bionic Man is featured in the fall issue of NIH's Medline Plus Magazine. The bionic man highlights fourteen technologies being developed by NIBIB-supported researchers, including advances in prostheses, brain-computer interfaces, and vaccine delivery. Read more at

Science Highlights • October 10, 2014
The Nobel Prize in Chemistry has been awarded to three researchers for bypassing a law of physics that was thought to limit the size of structures that could be viewed by an optical microscope.
Grantee News • October 9, 2014

NIBIB researchers have teamed-up with commercial partners to develop their "electronic skin" that looks like a tattoo but monitors and transmits data about the health status of the wearer. Applications include monitoring the movements of Parkinson's patients, remotely keeping tabs on your child's temperature, and even receiving an email from your wearable patch recommending the best skin care products based on your skin hydration and perspiration levels. Read more in the New York Times.

Science Highlights • October 2, 2014
A team of bioengineers, molecular biologists, and clinicians used a novel rare cell-sorter to isolate breast cancer cells from the blood of patients, with the aim of identifying the most effective drugs to treat each individual tumor. Circulating tumor cells (CTCs) were isolated and grown in the laboratory for extensive genetic analysis, which enabled the identification and testing of the most effective cancer-killing drugs for those tumors. The ability to perform such genetic analysis in the laboratory paves the way for providing the most effective treatment, not only initially, but throughout the course of the disease, as mutating tumors become resistant to certain drugs, but susceptible to others.
Science Highlights • October 1, 2014
Three new members have been appointed to the National Advisory Council for Biomedical Imaging and Bioengineering (NACBIB) of the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NACBIB meets three times per year to advise on policy and program priorities related to the conduct and support of research, training, health information dissemination, and other programs that address biomedical imaging, biomedical engineering, and associated technologies and modalities with biomedical applications. The NACBIB also provides second-level review for all applications for funding of research and training grants and cooperative agreements by the NIBIB.
Science Highlights • October 1, 2014
NIBIB-funded researchers report in a recent study that they were able to use human stem cells to grow brand new nerves in a rat model of spinal cord injury. The neurons grew tens of thousands of axons that extended the entire length of the spinal cord, out from the area of injury. The procedure employs induced pluripotent stem cells or iPSCs, which are stem cells that can be driven to become a specific cell type -- in this case nerve cells-- to repair an experimentally damaged spinal cord. The iPSCs were made using the skin cells of an 86 year old male, demonstrating that even in an individual of advanced age, the ability of the cells to be turned into a different cell type (pluripotency) remained.
Grantee News • September 26, 2014

A research team including NIBIB-funded scientists isolated circulating tumor cells (CTCs) in a mouse model of pancreatic cancer. Molecular analysis of the CTCs revealed distinct patterns of gene expression that were different from the primary pancreatic tumor. The surprising results identify potential new molecular targets that could lead to improved treatments for this deadly cancer. Read more in Bioscience Technology

NIBIB in the News • September 24, 2014

Case Western Reserve University’s synchrotron facility at Brookhaven National Laboratory is on its way to becoming the No. 1 beamline facility for biology in the world by early 2016, thanks to a jumpstart grant of $4.6 million from NIBIB. Read more at News Medical.

September 23, 2014

A third of patients who undergo surgery to remove cancerous tumors end up with microscopic pieces left behind. These overlooked remnants can lead to the recurrence of cancer after what was thought to be a successful surgery. Two surgeons at the University of Pennsylvania have joined forces to try to solve this problem. Read more at

NIBIB in the News • September 15, 2014

NIBIB Director Roderic Pettigrew discusses the recent spinal stimulation breakthrough for paralysis, other NIH-supported technologies for assisting individuals with paralysis or movement disorders, and future research directions in the Robert Wood Johnson Foundation's Human Capital blog. You can read the full post at